Department of Pharmacology, Yonsei University College of Medicine, Seoul, Korea.
Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institute, Yonsei University College of Medicine, Seoul, Korea.
Clin Transl Sci. 2022 Sep;15(9):2230-2240. doi: 10.1111/cts.13356. Epub 2022 Jul 5.
We aimed to develop a risk scoring system for 1-week and 1-month mortality after major non-cardiac surgery, and assess the impact of postoperative factors on 1-week and 1-month mortality using machine learning algorithms. We retrospectively reviewed the medical records of 21,510 patients who were transfused with red blood cells during non-cardiac surgery and collected pre-, intra-, and postoperative features. We derived two patient cohorts to predict 1-week and 1-month mortality and randomly split each of them into training and test cohorts at a ratio of 8:2. All the modeling steps were carried out solely based on the training cohorts, whereas the test cohorts were reserved for the evaluation of predictive performance. Incorporation of postoperative information demonstrated no significant benefit in predicting 1-week mortality but led to substantial improvement in predicting 1-month mortality. Risk scores predicting 1-week and 1-month mortality were associated with area under receiver operating characteristic curves of 84.58% and 90.66%, respectively. Brain surgery, amount of intraoperative red blood cell transfusion, preoperative platelet count, preoperative serum albumin, and American Society of Anesthesiologists physical status were included in the risk score predicting 1-week mortality. Postoperative day (POD) 5 (neutrophil count × mean platelet volume) to (lymphocyte count × platelet count) ratio, preoperative and POD 5 serum albumin, and occurrence of acute kidney injury were included in the risk score predicting 1-month mortality. Our scoring system advocates the importance of postoperative complete blood count differential and serum albumin to better predict mortality beyond the first week post-surgery.
我们旨在开发一种主要非心脏手术后 1 周和 1 个月死亡率的风险评分系统,并使用机器学习算法评估术后因素对 1 周和 1 个月死亡率的影响。我们回顾性地审查了在非心脏手术期间输注红细胞的 21510 名患者的病历,并收集了术前、术中和术后特征。我们得出了两个患者队列来预测 1 周和 1 个月的死亡率,并将每个队列随机分为 8:2 的训练和测试队列。所有的建模步骤都是仅基于训练队列进行的,而测试队列则保留用于评估预测性能。纳入术后信息在预测 1 周死亡率方面没有显著获益,但在预测 1 个月死亡率方面有显著改善。预测 1 周和 1 个月死亡率的风险评分与接受者操作特征曲线下的面积分别为 84.58%和 90.66%相关。预测 1 周死亡率的风险评分包括脑外科手术、术中红细胞输注量、术前血小板计数、术前血清白蛋白和美国麻醉师协会身体状况。预测 1 个月死亡率的风险评分包括术后第 5 天(中性粒细胞计数×平均血小板体积)至(淋巴细胞计数×血小板计数)比值、术前和术后第 5 天的血清白蛋白以及急性肾损伤的发生。我们的评分系统主张术后全血细胞计数差异和血清白蛋白的重要性,以更好地预测手术后第一周后的死亡率。